← 返回专利悬崖列表
CAS 89-78-1
(1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol
登记编号：TICA-035、LAMI-013、EMTR-032、BEPO-009
应用背景（按来源药适应症）
中风替格瑞洛急性冠脉综合征替格瑞洛心肌梗塞替格瑞洛外周血管疾病替格瑞洛HIV感染多替拉韦/拉米夫定/艾酚福韦HIV感染拉米夫定/富马酸替诺福韦二吡呋酯慢性乙型肝炎拉米夫定/富马酸替诺福韦二吡呋酯HIV感染比克恩丙诺乙型肝炎比克恩丙诺HIV感染依非韦伦/拉米夫定/富马酸替诺福韦二吡呋酯HIV感染恩曲他滨/富马酸磷丙替诺福韦获得性免疫缺损综合征恩曲他滨/富马酸磷丙替诺福韦进行性多病灶脑白质病恩曲他滨/富马酸磷丙替诺福韦HIV感染恩曲他滨/盐酸利匹韦林/富马酸替诺福韦二吡呋酯乙型肝炎拉米夫定慢性乙型肝炎拉米夫定HIV感染拉米夫定Rett综合征拉米夫定阿尔茨海默病拉米夫定视网膜脱离拉米夫定HIV感染恩曲他滨阿尔茨海默病恩曲他滨痴呆恩曲他滨轻度认知障碍恩曲他滨过敏性鼻炎苯磺贝他斯汀荨麻疹苯磺贝他斯汀痒疹苯磺贝他斯汀变应性结膜炎苯磺贝他斯汀常年性变应性鼻炎苯磺贝他斯汀感染性皮肤病苯磺贝他斯汀
来源药（使用该中间体的合成路线）
| 品种 | 梯队 | 到期年 |
|---|---|---|
| 替格瑞洛Ticagrelor | Tier B · 提前布局 | 2029 |
| 多替拉韦/拉米夫定/艾酚福韦Dolutegravir/Lamivudine/Tenofovir Alafenamide | Tier C · 观察 / 贸易 | - |
| 拉米夫定/富马酸替诺福韦二吡呋酯Lamivudine/Tenofovir Disoproxil Fumarate | Tier C · 观察 / 贸易 | - |
| 比克恩丙诺Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate | Tier B · 提前布局 | - |
| 依非韦伦/拉米夫定/富马酸替诺福韦二吡呋酯Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate | Tier C · 观察 / 贸易 | - |
| 恩曲他滨/富马酸磷丙替诺福韦Emtricitabine/Tenofovir Alafenamide Fumarate | Tier B · 提前布局 | - |
| 恩曲他滨/盐酸利匹韦林/富马酸替诺福韦二吡呋酯Emtricitabine/Rilpivirine Hydrochloride/Tenofovir Disoproxil Fumarate | Tier B · 提前布局 | - |
| 拉米夫定Lamivudine | Tier C · 观察 / 贸易 | - |
| 恩曲他滨Emtricitabine | Tier C · 观察 / 贸易 | - |
| 苯磺贝他斯汀Bepotastine besilate | Tier C · 观察 / 贸易 | - |
合成路线中的位置（上下游链）
按路线登记顺序排列，左→右为合成方向；高亮为当前 CAS，其余可点击跳转对应档案。
(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine→3,4-difluorobenzaldehyde→malonic acid→(E)-3-(3,4-difluorophenyl)acrylic acid→(E)-3-(3,4-difluorophenyl)acryloyl chloride→(1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol→(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (E)-3-(3,4-difluorophenyl)acrylate→(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylate→(1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylic acid→(1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carbonyl azide
4-aminopyrimidin-2(1H)-one→(1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol→2-oxoacetic acid hydrate→(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 2-oxoacetate→1,4-dithiane-2,5-diol→(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate→(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate→(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate
(1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol→(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate→2-mercaptoacetic acid→2-oxoacetic acid→5-oxo-1,3-oxathiolane-2-carboxylic acid→(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-oxo-1,3-oxathiolane-2-carboxylate→(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate→(2S,5R)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate
4-aminopyrimidin-2(1H)-one→(1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol→2-oxoacetic acid hydrate→(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 2-oxoacetate→1,4-dithiane-2,5-diol→(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate→(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate→(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate
(1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol→(2R,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate→2-mercaptoacetic acid→2-oxoacetic acid→5-oxo-1,3-oxathiolane-2-carboxylic acid→(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-oxo-1,3-oxathiolane-2-carboxylate→(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate→(2S,5R)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate
本站可供应的对应中间体
同 CAS 多家在售供应横向对比；价格区间为供应方挂牌口径，实价以询价确认为准。
本页为中间体 CAS 注册档案：同 CAS 的多条路线登记已合并；后续供应商报价与买方需求以该 CAS 为主键撮合。